When
real news fade, rumors seem to crop up a little more readily. In the
case of the rumor that Baxter
(NYSE:BAX)
is arranging a bid for Gambro,
however, there's a little more credibility than usual. Baxter has
long wanted Gambro, and the combination would make sense in a
med-tech market where growth is increasingly hard to come by.
For the full article please continue here:
http://www.investopedia.com/
No comments:
Post a Comment